Exercise induced immune regulation and drug efficacy in rhinitis nasopharyngeal carcinoma implications for tumor microenvironment single cell immune signal transduction

Guanwen He, Weijing Bao, Jiansheng Yang, Xiuqin Guo, Wenxian Lu, X. B. Ji, Shang Gao, Rifu Wei, Yisheng ChenFrontiers in Immunology 2025 · DOI

This review, published in Frontiers in Immunology, explores the emerging role of exercise as a biological "adjuvant" that enhances the efficacy of pharmacological and immune-based therapies. By synthesizing recent findings in allergic rhinitis (AR) and nasopharyngeal carcinoma (NPC), the authors highlight how physical activity reshapes the tumor microenvironment (TME) and immune signaling pathways at a single-cell level.

TL;DR

Exercise acts as a potent regulator of the immune system, improving drug delivery and "priming" the tumor microenvironment to make immunotherapies more effective. By leveraging single-cell technologies, researchers are uncovering how tailored exercise regimens can overcome immune evasion and improve clinical outcomes for patients with respiratory allergies and head-and-neck cancers.

What Problem Does This Paper Address?

Despite advancements in immunotherapy (like checkpoint inhibitors), many patients with nasopharyngeal carcinoma (NPC) show modest response rates due to a "cold" or immunosuppressive tumor microenvironment (TME). Similarly, in allergic rhinitis (AR), drug efficacy is often limited by poor local circulation and persistent inflammation.

The authors address the gap between lifestyle interventions and clinical pharmacology. They investigate whether exercise can be systematically integrated into treatment protocols to solve three main challenges:

  1. Poor Drug Bioavailability: Inefficient blood flow and "leaky" tumor vasculature prevent drugs from reaching their targets.
  2. Immune Evasion: Tumors create "shields" using regulatory T cells (Tregs) and myeloid-derived suppressor cells (MDSCs).
  3. Treatment Side Effects: High-dose therapies often lead to poor patient compliance due to toxicity.

Methods

As a Mini Review, this paper does not present a single new experiment but rather synthesizes data from a wide range of preclinical animal models and human clinical trials.

A key focus of the review is the application of single-cell RNA sequencing (scRNA-seq) and spatial omics. The authors argue that these high-resolution techniques are essential for moving beyond "bulk" observations to understand exactly how exercise re-wires the signal transduction between specific immune cell subsets (e.g., how a 30-minute run changes the interaction between a dendritic cell and a cytotoxic T cell within a tumor).

Datasets

Not discussed in the paper. (As a review article, it references various external datasets from the cited primary research).

Key Insights and Ideas

  • Vascular Normalization: One of the most critical "aha" moments is that aerobic exercise helps "normalize" tumor blood vessels. Instead of the chaotic, leaky vessels typical of tumors, exercise-induced pressure helps create more structured vessels, reducing hypoxia (oxygen starvation) and allowing drugs and immune cells to penetrate deeper into the tumor.
  • The Intensity "Sweet Spot": The paper highlights the "open window" phenomenon. While Moderate-Intensity Exercise (MIE) boosts immune surveillance and cytokine shifts, High-Intensity Exercise (HIE) can cause transient immunosuppression and elevated stress hormones, which might actually impair drug efficacy if not timed correctly.
  • Metabolic and Signaling Reprogramming: Exercise doesn't just move cells around; it changes their "software." It can downregulate PD-L1 expression on tumor cells (making them easier for the immune system to see) and increase the secretion of anti-tumor cytokines like IL-6 and TNF-α.
  • Synergy with Montelukast: In AR, the combination of exercise and Montelukast (a common allergy med) showed better results than either alone, suggesting that exercise improves the pharmacokinetics of the drug by enhancing nasal mucosal blood flow.

Key Results

  • In NPC: Clinical studies cited show that exercise during Immune Checkpoint Inhibitor (ICI) therapy improves Overall Survival (OS) and Progression-Free Survival (PFS) while significantly reducing treatment-related fatigue.
  • In AR: Moderate exercise was shown to reduce airway inflammation and nasal congestion by increasing anti-inflammatory cytokines like IL-10.
  • Cellular Infiltration: Preclinical models consistently show that exercise increases the infiltration of CD8+ T cells and Natural Killer (NK) cells into the TME while reducing the accumulation of immunosuppressive MDSCs.

Limitations and Future Work

The authors acknowledge several hurdles before "exercise prescriptions" become standard in oncology:

  • Lack of Standardization: There is currently no universal agreement on the optimal "dose" (type, intensity, duration) of exercise for different cancer stages.
  • Inter-individual Variability: Factors like age, baseline fitness, and genetics mean two patients might have vastly different immune responses to the same exercise.
  • Biomarker Discovery: Future work needs to identify specific molecular biomarkers that can predict which patients will benefit most from exercise-integrated immunotherapy.
  • Integration of Omics: The authors call for more studies using spatial CITE-seq and CRISPR screening to map the exact "intercellular conversations" triggered by exercise.

Summary updated

Abstract

Emerging evidence reveals that exercise modulates immune signaling to enhance the efficacy of immunotherapy in diseases like allergic rhinitis (AR) and nasopharyngeal carcinoma (NPC). By influencing immune cell trafficking, reprogramming inflammatory pathways within the tumor microenvironment (TME), and altering drug pharmacokinetics, exercise improves immune responses and therapeutic outcomes. Exercise enhances immune cell activation and infiltration into tumors, modulates checkpoint and cytokine signaling cascades, and mitigates treatment-related side effects, thereby improving patient compliance. Recent advancements in single-cell technologies, such as single-cell RNA sequencing and spatial omics, provide unprecedented insights into immune cell heterogeneity and signal transduction dynamics in the TME, uncovering new targets for exercise-modulated therapies. This review explores the synergistic effects of combining exercise with immune-based therapies, particularly in cancer treatment, highlighting the role of exercise in reshaping TME inflammation, overcoming immune evasion, and enhancing immune-mediated drug bioavailability. Personalized exercise regimens, tailored to individual patient profiles, are critical for optimizing therapeutic responses. Integrating exercise with immunotherapy, guided by single-cell and systems-level analyses, may provide a transformative approach for improving the clinical outcomes of AR and NPC patients, paving the way for more effective, individualized cancer treatments.
BibTeX
@inproceedings{he2025exercise,
  author = {Guanwen He and Weijing Bao and Jiansheng Yang and Xiuqin Guo and Wenxian Lu and X. B. Ji and Shang Gao and Rifu Wei and Yisheng Chen},
  title = {{Exercise induced immune regulation and drug efficacy in rhinitis nasopharyngeal carcinoma implications for tumor microenvironment single cell immune signal transduction}},
  booktitle = {Frontiers in Immunology},
  year = {2025},
  doi = {10.3389/fimmu.2025.1673383},
}
Figure